Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3363
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03706521 | MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee Osteoarthritis | ||
| NCT00386516 | Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer | ||
| NCT04708314 | An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy | ||
| NCT00456521 | A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program | ||
| NCT01746784 | Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation | ||
| NCT01737814 | Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) | ||
| NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | ||
| NCT02502409 | Natural History Study of Factor IX Treatment and Complications | ||
| NCT05443984 | JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis | ||
| NCT01027364 | Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B | ||
| NCT01517464 | A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors | ||
| NCT06964009 | DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer | ||
| NCT02666664 | Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony) | ||
| NCT06592664 | Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC | ||
| NCT05596409 | ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study | ||
| NCT03041311 | Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC | ||
| NCT04786964 | Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC | ||
| NCT05972044 | A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) | ||
| NCT01632332 | Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer | ||
| NCT02609763 | Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS) Scale | ||
| NCT05104463 | A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease | ||
| NCT03061721 | Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis | ||
| NCT04908514 | A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis | ||
| NCT02335814 | First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT05437263 | A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis | ||
| NCT05133336 | Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis | ||
| NCT07396909 | A First-in-Human Single and Multiple Ascending Dose Study of MT-701 | ||
| NCT05271552 | Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II) | ||
| NCT03493698 | A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects | ||
| NCT02270463 | SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission | ||
| NCT07400588 | Aleniglipron Phase 2 in Type 2 Diabetes Mellitus | ||
| NCT03534622 | Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults | ||
| NCT05027581 | Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA) | ||
| NCT04557800 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL151 in Healthy Volunteers | ||
| NCT05241470 | Study of ST-100 as Treatment for Dry Eye Disease | ||
| NCT01969565 | Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma | ||
| NCT01577459 | A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response | ||
| NCT06533059 | A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors | ||
| NCT04737486 | A First-in-Human Study of AV-001 in Healthy Subjects | ||
| NCT02324673 | Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders | ||
| NCT02718495 | Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis | ||
| NCT04246866 | First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration | ||
| NCT03758339 | A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants | ||
| NCT07027111 | Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP | ||
| NCT02831231 | Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium | ||
| NCT04534439 | Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy | ||
| NCT01521819 | Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration | ||
| NCT02958930 | Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease | ||
| NCT01414881 | Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects | ||
| NCT05844592 | First in Human, Single Ascending Dose Study |
